SKIP TO CONTENT
Johns Hopkins
  • Home
  • About
  • News
  • Contact
  • Login

    • Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models

    In a new study led by Johns Hopkins Medicine, the experimental drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis), which is often incurable. Researchers say this study moves them closer to clinical trials for RK-33.

    LEARN MORE
    SEE ALL NEWS
    Recent Posts
    Why There *Still* Isn’t a Routine Screening Exam for Ovarian Cancer Instruments of Healing Five-Year Analysis Shows Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery Significantly Improves Long-Term Survival Johns Hopkins Medicine Sparks Hope, Confidence for Woman with Rare Head and Neck Cancer Combining Laboratory Techniques Yields Wealth of Information About Deadly Brain Tumors Fluorescent Imaging Breakthrough Helps Johns Hopkins Surgeons Target Hidden Lung Tumors Cal Ripken Jr.’s Prostate Cancer Journey How women are beating gynecological cancers Sunscreen and Your Morning Routine
    Johns Hopkins

    2025 © The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
    Terms of Use Privacy Statement

    LinkedIn
    Back to top